Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
60 participants
OBSERVATIONAL
2023-05-31
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Advanced Fetal Imaging - Phase II
NCT02840019
Magnetic Resonance Imaging (MRI) of Ventriculomegaly: Morphology and Outcome
NCT00870675
Placenta Imaging Project
NCT02749851
Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams
NCT00738712
Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation
NCT01007357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this project the investigators will develop software that runs on the Siemens MRI scanner. This software will improve the workflow for fetal imaging i.e. for imaging the fetus in utero. Fetal imaging in its current form is inefficient due to the frequent motion of the fetus during the imaging procedure. In this project the investigators will develop automated methods for alignment and tracking of the fetus during imaging, to more efficiently image the fetus and to obtain better image quality in a shorter examination. The investigators are specifically interested in the fetal brain, but these methods may be generalized to all fetal organ systems. The investigators will install the software on the scanner and test these methods with volunteers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant women presenting for MRI
Alternative motion-robust MR imaging sequences and procedures for automatic positioning while be tested during fetal brain imaging
No intervention - the investigators are evaluating a new image acquisition method on an MRI scanner
The investigators will evaluate the performance of a modified MRI acquisition method against an existing method in fetal imaging in volunteers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention - the investigators are evaluating a new image acquisition method on an MRI scanner
The investigators will evaluate the performance of a modified MRI acquisition method against an existing method in fetal imaging in volunteers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* MRI contraindications (e.g., magnetically or mechanically activated implants)
* Weight greater than or equal to 300lbs (weight limit of the MRI table)
* Non-English speaking
* Neurological conditions (i.e. epilepsy, multiple sclerosis, neurodegenerative diseases, memory disorders, brain tumor)
* Past incidence of stroke or heart attack
* Severe hypertension, blood disorders, advanced diabetes mellitus, or advanced cardiovascular disease
* Hospitalization within 6 weeks prior to enrollment
* Significant acute and/or chronic medical conditions, current use of medications that indicate the existence of significant medical conditions, and other unspecified reasons that make the subject unsuitable for enrollment at the discretion at the PI and a consulting MD.
Pregnant mothers with the following features will be excluded.
* Mothers with contraindication to MRI (such as pacemaker, metal in body, exceeding scanner weight or bore diameter limits (550lbs, 70cm))
* Mothers with claustrophobia
* Mothers medically unstable for the MRI study
13 Weeks
40 Weeks
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andre van der Kouwe, PhD
Dr. Andre van der Kouwe
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021P001433
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.